ERC Synergy Grant to PACE: Could Parkinson's disease begin in the skin?

PACE Director, Professor Per Borghammer, together with Professor Nathalie Van Den Berge (Aarhus University) and Avraham Ashkenazi (Tel Aviv University), receives the prestigious European Research Council (ERC) Synergy Grant to investigate the origins of Parkinson’s disease.

From left: Nathalie Van Den Berge, Avraham Ashkenazi, Per Borghammer

Parkinson’s disease is the fastest-growing neurodegenerative disorder worldwide, yet scientists still do not understand how or where it begins. This project, DERMIS-PD “The Hidden Entry: How Skin and Environment Shape Parkinson’s Disease”, investigates a ground-breaking hypothesis: Could Parkinson’s disease begin in the skin, years before its characteristic movement symptoms appear?

Although Parkinson’s disease has traditionally been associated with the degeneration of neurons in the brain, growing evidence suggests that in some patients, the sympathetic nervous system, which regulates involuntary functions such as heart activity and blood pressure, is affected long before motor symptoms emerge. One striking manifestation is early loss of sympathetic nerve connections to the heart, sometimes described as the “invisible heart.”

The researchers will investigate whether environmental toxicants, including pesticides, industrial solvents and persistent chemicals, can trigger disease-related changes in sympathetic nerve endings in the skin, potentially initiating a previously unrecognized pathway of Parkinson’s disease.

To address this challenge, the three teams will combine complementary expertise: Van Den Berge will investigate disease initiation and progression using advanced animal models; Borghammer will study environmental exposures and early disease signatures in deeply characterized patient cohorts; and Ashkenazi will uncover underlying molecular mechanisms using human stem cell-derived sympathetic neurons and innovative ganglia-on-chip technologies.

“Parkinson’s disease begins many years before the first movement symptoms appear,” say the researchers. “By understanding how environmental exposures interact with the vulnerability of specific nerve cells, we hope to uncover the earliest mechanisms of the disease and open new possibilities for early detection and prevention.”